KR vs PPCB · P/E 19, rev $147.12B vs P/E 0.0, $3.9M cap
Kroger Company (KR) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
PPCB does not have a complete income-statement cache yet.
KR currently screens at market cap $46.17B and trailing P/E 19.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the KR and PPCB stock pages for the full models.
Not investment advice.